These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 31229666)
41. Cytomegalovirus-specific CD4+ and CD8+ T-cells follow a similar reconstitution pattern after allogeneic stem cell transplantation. Foster AE; Gottlieb DJ; Sartor M; Hertzberg MS; Bradstock KF Biol Blood Marrow Transplant; 2002; 8(9):501-11. PubMed ID: 12374455 [TBL] [Abstract][Full Text] [Related]
42. Expansion of human CMV-specific cytotoxic T lymphocytes to a clinical scale: a simple culture system using tetrameric HLA-peptide complexes. Watanabe N; Kamachi Y; Koyama N; Hama A; Liang J; Nakamura Y; Yamamoto T; Isomura M; Kudo K; Kuzushima K; Kojima S Cytotherapy; 2004; 6(5):514-22. PubMed ID: 15512918 [TBL] [Abstract][Full Text] [Related]
43. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses. Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490 [TBL] [Abstract][Full Text] [Related]
44. A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks. Palmerini P; Dalla Pietà A; Sommaggio R; Ventura A; Astori G; Chieregato K; Tisi MC; Visco C; Perbellini O; Ruggeri M; Cappuzzello E; Rosato A Cytotherapy; 2020 Sep; 22(9):511-518. PubMed ID: 32631696 [TBL] [Abstract][Full Text] [Related]
45. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients]. Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495 [TBL] [Abstract][Full Text] [Related]
46. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells. Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339 [TBL] [Abstract][Full Text] [Related]
47. Generation of cytomegalovirus (CMV)-specific CD4 T cell lines devoid of alloreactivity, by use of a mixture of CMV-phosphoprotein 65 peptides for reconstitution of the T helper repertoire. Li Pira G; Bottone L; Ivaldi F; Tagliamacco A; Fiordoro S; Ricciardi A; Barbano G; Manca F J Infect Dis; 2005 Jan; 191(2):215-26. PubMed ID: 15609231 [TBL] [Abstract][Full Text] [Related]
48. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection. Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694 [TBL] [Abstract][Full Text] [Related]
49. Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression. Wehler TC; Karg M; Distler E; Konur A; Nonn M; Meyer RG; Huber C; Hartwig UF; Herr W J Immunol Methods; 2008 Nov; 339(1):23-37. PubMed ID: 18760281 [TBL] [Abstract][Full Text] [Related]
50. Identification of immune dominant cytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-gamma production by peptide-stimulated peripheral blood mononuclear cells. Provenzano M; Mocellin S; Bettinotti M; Preuss J; Monsurrò V; Marincola FM; Stroncek D J Immunother; 2002; 25(4):342-51. PubMed ID: 12142557 [TBL] [Abstract][Full Text] [Related]
51. Persistent cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients. Shlobin OA; West EE; Lechtzin N; Miller SM; Borja M; Orens JB; Dropulic LK; McDyer JF J Immunol; 2006 Feb; 176(4):2625-34. PubMed ID: 16456025 [TBL] [Abstract][Full Text] [Related]
52. Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response size. Chiu YL; Lin CH; Sung BY; Chuang YF; Schneck JP; Kern F; Pawelec G; Wang GC Sci Rep; 2016 Jan; 6():19227. PubMed ID: 26778409 [TBL] [Abstract][Full Text] [Related]
53. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants. Lucas KG; Sun Q; Burton RL; Tilden A; Vaughan WP; Carabasi M; Salzman D; Ship A Hum Gene Ther; 2000 Jul; 11(10):1453-63. PubMed ID: 10910142 [TBL] [Abstract][Full Text] [Related]
54. CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients. Makwana N; Foley B; Fernandez S; Lee S; Irish A; Pircher H; Price P Eur J Immunol; 2017 Aug; 47(8):1324-1334. PubMed ID: 28586095 [TBL] [Abstract][Full Text] [Related]
55. Long-term stable expanded human CD4+ T cell clones specific for human cytomegalovirus are distributed in both CD45RAhigh and CD45ROhigh populations. Weekes MP; Wills MR; Sissons JG; Carmichael AJ J Immunol; 2004 Nov; 173(9):5843-51. PubMed ID: 15494538 [TBL] [Abstract][Full Text] [Related]
56. Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion. Liu J; Wang L; Wang Y; Zhang W; Cao Y PLoS One; 2017; 12(4):e0175704. PubMed ID: 28426690 [TBL] [Abstract][Full Text] [Related]
57. Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation. Link CS; Eugster A; Heidenreich F; Rücker-Braun E; Schmiedgen M; Oelschlägel U; Kühn D; Dietz S; Fuchs Y; Dahl A; Domingues AM; Klesse C; Schmitz M; Ehninger G; Bornhäuser M; Schetelig J; Bonifacio E Clin Exp Immunol; 2016 Jun; 184(3):389-402. PubMed ID: 26800118 [TBL] [Abstract][Full Text] [Related]
58. Specific activation of CMV-primed human T lymphocytes by cytomegalovirus pp65 expressed in fission yeast. Breinig F; Heintel T; Schumacher A; Meyerhans A; Schmitt MJ FEMS Immunol Med Microbiol; 2003 Oct; 38(3):231-9. PubMed ID: 14522458 [TBL] [Abstract][Full Text] [Related]
59. The matrix protein pp65(341-350): a peptide that induces ex vivo stimulation and in vitro expansion of CMV-specific CD8+ T cells in subjects bearing either HLA-A*2402 or A*0101 allele. Provenzano M; Lim JB; Mocellin S; Monsurro V; Bettinotti M; Marincola FM; Stroncek DF Transfusion; 2003 Nov; 43(11):1567-74. PubMed ID: 14617317 [TBL] [Abstract][Full Text] [Related]
60. Strong and sustained effector function of memory- versus naïve-derived T cells upon T-cell receptor RNA transfer: implications for cellular therapy. Thomas S; Klobuch S; Besold K; Plachter B; Dörrie J; Schaft N; Theobald M; Herr W Eur J Immunol; 2012 Dec; 42(12):3442-53. PubMed ID: 22930221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]